WUXI BIOLOGICS CAYMAN INC ADR's ticker is WXXWY and the CUSIP is 98260N108. A total of 10 filers reported holding WUXI BIOLOGICS CAYMAN INC ADR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,095 | -46.8% | 1,417 | -33.9% | 0.00% | – |
| Q1 2024 | $7,701 | -33.7% | 2,145 | +37.7% | 0.00% | – |
| Q4 2023 | $11,607 | -44.1% | 1,558 | -12.9% | 0.00% | – |
| Q3 2023 | $20,752 | +74.2% | 1,789 | +43.9% | 0.00% | – |
| Q2 2023 | $11,912 | -29.8% | 1,243 | -9.3% | 0.00% | – |
| Q1 2023 | $16,963 | +1.4% | 1,370 | +25.6% | 0.00% | – |
| Q4 2022 | $16,732 | +52.1% | 1,091 | +19.8% | 0.00% | – |
| Q3 2022 | $11,000 | -50.0% | 911 | -22.3% | 0.00% | – |
| Q2 2022 | $22,000 | +450.0% | 1,172 | +430.3% | 0.00% | – |
| Q1 2022 | $4,000 | -73.3% | 221 | -65.4% | 0.00% | – |
| Q4 2021 | $15,000 | -21.1% | 638 | +9.1% | 0.00% | – |
| Q3 2021 | $19,000 | -13.6% | 585 | -3.1% | 0.00% | – |
| Q2 2021 | $22,000 | +120.0% | 604 | +47.7% | 0.00% | – |
| Q1 2021 | $10,000 | – | 409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMAS WHITE INTERNATIONAL LTD | 314,845 | $7,906,000 | 1.18% |
| EQUITABLE TRUST CO | 175,482 | $4,395,000 | 0.33% |
| MAI Capital Management | 22,885 | $584,000 | 0.01% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 31,864 | $813,000 | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 31,754 | $810,000 | 0.01% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 635,605 | $16,214,000 | 0.01% |
| Eudaimonia Partners, LLC | 1,541 | $39,000 | 0.01% |
| SVB WEALTH LLC | 8,855 | $221,000 | 0.00% |
| First Horizon Advisors, Inc. | 2,202 | $55,000 | 0.00% |
| IFP Advisors, Inc | 3,654 | $92,000 | 0.00% |